Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MRNA)

Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting

Accesswire 5 hours ago

Moderna to Present at Upcoming Conferences in May/June 2024

Accesswire 9 days ago

Moderna Announces Update on Investigational RSV Vaccine

Accesswire 12 days ago

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Accesswire May 2, 2024

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress

Accesswire April 25, 2024

Moderna and OpenAI Collaborate To Advance mRNA Medicine

Accesswire April 24, 2024

Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign

Accesswire April 22, 2024

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024

Accesswire April 17, 2024

Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

Accesswire April 3, 2024
View More News ››

Opinion & Analysis (NDAQ:MRNA)

Memphasys, Moderna, Paion - Investments in solutions with potential

Stockhouse Editorial June 2, 2020

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data

Streetwise Reports May 19, 2020

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

Streetwise Reports April 23, 2020

U.S.-Based Biotech 'Growing into a Giant with AI'

Streetwise Reports March 9, 2020

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study

Streetwise Reports February 26, 2020

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Streetwise Reports September 13, 2019
View More Opinion ››

Bullboard Posts (NDAQ:MRNA)

Oracle, Moderna, Palantir Technologies And A Big Bank On CNB

JUST IN: $MRNA Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC's 'Final Trades' | BenzingaOn CNBC@s @Halftime...
whytestocks - 6 minutes ago

Moderna Announces Data to be Presented at 2024 ASCO Annual M

News; $MRNA Moderna Announces Data to be Presented at 2024 ASCO Annual MeetingModerna to host an investor event via webcast on Monday...
whytestocks - 21 minutes ago

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For

Just In: $MRNA Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars...
whytestocks - May 2, 2024

Moderna (MRNA) Q1 2024 Earnings Call Transcript

NEWS: $MRNA Moderna (MRNA) Q1 2024 Earnings Call Transcript2024-05-02 12:30:13 ET Image source: The Motley Fool. Moderna (NASDAQ: MRNA...
whytestocks - May 2, 2024

Should You Buy Moderna Before May 12?

Just In: $MRNA Should You Buy Moderna Before May 12?2024-04-26 04:50:00 ET Moderna (NASDAQ: MRNA) stock soared earlier in the pandemic...
whytestocks - April 26, 2024

Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Tradi

NEWS: $MRNA Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage GainModerna, Inc. (NASDAQ: MRNA) is one...
whytestocks - April 9, 2024
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »